Anthonisen NR, Connett JE,
Kiley JP, Altose MD, Bailey WC, Buist AS, et al: Effects of smoking
intervention and the use of an inhaled anticholinergic bronchodilator on
the rate of decline of FEV1. The Lung Health Study. JAMA
Burge PS, Calverley PM,
Jones PW, Spencer S, Anderson JA, Maslen TK: Randomised, double blind,
placebo controlled study of fluticasone propionate in patients with
moderate to severe chronic obstructive pulmonary disease: The ISOLDE
Trial. BMJ 2000;320:1297-1303.
Dale LC, Ebbert JO, Hays
JT, Hurt RD: Treatment of nicotine dependence. Mayo Clinic Proc
Ferguson GT, Enright PL,
Buist AS, Higgins MW: Office spirometry for lung health assessment in
adults. A consensus statement from the National Lung Health Education
Program. Chest 2000;117:1146-1161.
Guyatt GH, Townsend M,
Nogradi S, et al: Acute response to bronchodilator — an imperfect guide
for bronchodilator therapy. Arch Intern Med 1988;148:1949-1952.
Hankinson JL, Odencrantz
JR, Fedan KB: Spirometric reference values from a sample of the general
U.S. population. Am J Respir Crit Care Med 1999;159:179-187.
Hurt RD, Sachs DP, Glover
ED, Offord KP, Johnston JA, Dale LC, et al: A comparison of
sustained-released bupropion and placebo for smoking cessation. N Engl J
Jorenby DE, Lieschow SJ,
Nides MA, Rennard SI, Johnston JA, Hughes AR, et al: A controlled trial of
sustained-release bupropion, a nicotine patch, or both for smoking
cessation. N Engl J Med 1999;340:685-691.
Lung Health Study Research
Group: Effect of inhaled triamcinolone on the decline in pulmonary
function in chronic obstructive pulmonary disease. New Engl J Med
Mannino DM, Gagnon RC,
Petty TL, Lydick E: Obstructive lung disease and low lung function in
adults in the United States. Arch Intern Med 2000;160:1683-1689.
Niewoehner DE, Erbland ML,
Deupree RH, Collins D, Gross NJ, Light RW, et al: Effect of systemic
glucocorticoids on exacerbations of chronic obstructive pulmonary disease.
Department of Veterans Affairs Cooperative Study Group. N Engl J Med
Peto R, Speizer FE,
Cochrane AL, Moore F, Fletcher CM, Tinker CM, et al: The relevance in
adults of air-flow obstruction, but not of mucus hypersecretion, to
mortality from chronic lung disease. Results from 20 years of prospective
observation. Am Rev Respir Dis 1983;128:491500.
Soriano JB, Vestbo J, Pride
NB, et al: Sirvival in COPD patients after regular use of fluticasone
propionate and salmuterol in general practice. Evidence of improved
survival in COPD patients with the regular use of both agents. Eur Respir
J 2002; 20:819-825.
Swanney MP, Jensen RL,
Crichton DA, Beckert LE, Cardno LA, Crapo RO: FEV6 is an acceptable
surrogate for FVC in the spirometric diagnosis
of airway obstruction
and restriction. Am J Respir Crit Care Med 2000;162:917-919.
Vinken W, et al: Improved
health outcomes in patients with COPD during one year’s treatment with
tiotropium. Eur Respir J 2002;19:209-216.